CL2011000789A1 - Inhalador de medicamento, comprende una base que contiene al menos una cavidad con medicamento, una porcion de lamina metalica desprendible que cubre dicha cavidad, un elemento de separacion y un accionador que engancha el elemento de separacion, para separar la porcion de lamina, y un seguro accionado por un flujo de inhalacion - Google Patents

Inhalador de medicamento, comprende una base que contiene al menos una cavidad con medicamento, una porcion de lamina metalica desprendible que cubre dicha cavidad, un elemento de separacion y un accionador que engancha el elemento de separacion, para separar la porcion de lamina, y un seguro accionado por un flujo de inhalacion

Info

Publication number
CL2011000789A1
CL2011000789A1 CL2011000789A CL2011000789A CL2011000789A1 CL 2011000789 A1 CL2011000789 A1 CL 2011000789A1 CL 2011000789 A CL2011000789 A CL 2011000789A CL 2011000789 A CL2011000789 A CL 2011000789A CL 2011000789 A1 CL2011000789 A1 CL 2011000789A1
Authority
CL
Chile
Prior art keywords
cavity
separation element
medicine
actuator
insurance
Prior art date
Application number
CL2011000789A
Other languages
English (en)
Spanish (es)
Inventor
William Bakewell
John Briant
Patrick Cambell
Charles Cooke
Christopher Groombrige
Nicholas Harrison
James Dan John
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CL2011000789A1 publication Critical patent/CL2011000789A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0043—Non-destructive separation of the package, e.g. peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0096—Hindering inhalation before activation of the dispenser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/06—Containers or packages with special means for dispensing contents for dispensing powdered or granular material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073—Syringe, piston type

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CL2011000789A 2008-10-08 2011-04-08 Inhalador de medicamento, comprende una base que contiene al menos una cavidad con medicamento, una porcion de lamina metalica desprendible que cubre dicha cavidad, un elemento de separacion y un accionador que engancha el elemento de separacion, para separar la porcion de lamina, y un seguro accionado por un flujo de inhalacion CL2011000789A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10360608P 2008-10-08 2008-10-08

Publications (1)

Publication Number Publication Date
CL2011000789A1 true CL2011000789A1 (es) 2011-10-21

Family

ID=42100804

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000789A CL2011000789A1 (es) 2008-10-08 2011-04-08 Inhalador de medicamento, comprende una base que contiene al menos una cavidad con medicamento, una porcion de lamina metalica desprendible que cubre dicha cavidad, un elemento de separacion y un accionador que engancha el elemento de separacion, para separar la porcion de lamina, y un seguro accionado por un flujo de inhalacion

Country Status (17)

Country Link
US (1) US9095670B2 (https=)
EP (1) EP2334358B1 (https=)
JP (1) JP5518082B2 (https=)
KR (1) KR20110074766A (https=)
CN (1) CN102245239B (https=)
AU (1) AU2009302956B8 (https=)
BR (1) BRPI0920658A2 (https=)
CA (1) CA2738822A1 (https=)
CL (1) CL2011000789A1 (https=)
EA (1) EA019293B1 (https=)
ES (1) ES2579902T3 (https=)
IL (1) IL212074A0 (https=)
MX (1) MX2011003759A (https=)
NZ (1) NZ591956A (https=)
UA (1) UA101056C2 (https=)
WO (1) WO2010042033A1 (https=)
ZA (1) ZA201103334B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005057685A1 (de) * 2005-12-01 2007-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung
US9889087B2 (en) * 2014-06-10 2018-02-13 The Board Of Trustees Of The Leland Stanford Junior University Intranasal delivery of β2-adrenergic receptor agonists for improving cognition in humans with down syndrome and compositions therefor
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
SG11201811491YA (en) 2016-06-27 2019-01-30 Achillion Pharmaceuticals Inc Quinazoline and indole compounds to treat medical disorders
GB2553534A (en) 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechanism for an inhaler
GB201615186D0 (en) * 2016-09-07 2016-10-19 3M Innovative Properties Co Energy storage mechanism for an inhaler
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
PE20200432A1 (es) 2017-03-15 2020-02-28 Csp Technologies Inc Inhalador y metodo de uso y de fabricacion del mismo
CN110271772B (zh) * 2018-03-13 2023-09-15 李和伟 一种给药器
US20230022157A1 (en) 2018-08-20 2023-01-26 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
US12053069B2 (en) 2019-01-22 2024-08-06 Coopervision International Limited Contact lens blister package with double layer foil component
US11419397B2 (en) 2019-01-22 2022-08-23 Coopervision International Limited Push-up contact lens blister package
US11253035B2 (en) 2019-01-22 2022-02-22 Coopervision International Holding Company, Lp Blister package for contact lens
US11267643B2 (en) 2019-01-22 2022-03-08 Coopervision International Limited Contact lens dispenser
US11136176B2 (en) 2019-01-22 2021-10-05 Coopervision International Limited Contact lens blister package with lens cradle
US11229266B2 (en) 2019-01-22 2022-01-25 Coopervision International Limited Tessellating blister packages for contact lenses
WO2021127452A1 (en) 2019-12-19 2021-06-24 Georgia State University Research Foundation, Inc. Compounds for the treatment of bacterial infections and potentiation of antibiotics
CN115362162A (zh) 2020-02-20 2022-11-18 艾其林医药公司 用于治疗补体因子d介导的障碍的杂芳基化合物
CN116437913A (zh) 2020-09-23 2023-07-14 艾其林医药公司 用于治疗补体介导的病症的药物化合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024760D0 (en) 1990-11-14 1991-01-02 Riker Laboratories Inc Inhalation device and medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5823183A (en) 1995-08-02 1998-10-20 Innovative Devices Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
EP0938907B1 (en) 1996-01-03 2001-12-05 Glaxo Group Limited Inhalation device
WO1999027987A1 (en) 1997-12-02 1999-06-10 Dura Pharmaceuticals, Inc. Dry powder inhaler
NL1008031C2 (nl) * 1998-01-15 1999-07-21 Pharmachemie Bv Inrichting voor het inhaleren van medicament.
GB9905538D0 (en) 1999-03-10 1999-05-05 Glaxo Group Ltd A device
US6880555B1 (en) 1999-10-12 2005-04-19 Shl Medical Ab Inhaler
US7171965B2 (en) 2000-02-01 2007-02-06 Valois S.A.S. Breath actuated dry powder inhaler and tape dose strip
AU2001250901A1 (en) 2000-03-27 2001-10-08 Dura Pharmaceuticals, Inc. Containers for individual doses of an inhalable pharmaceutical
SE517227C2 (sv) 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
GB0120018D0 (en) * 2001-08-16 2001-10-10 Meridica Ltd Pack containing medicament and dispensing device
JP4261351B2 (ja) 2001-09-19 2009-04-30 アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド 吸入器
US6941947B2 (en) 2002-12-18 2005-09-13 Quadrant Technologies Limited Unit dose dry powder inhaler
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
GB0322544D0 (en) * 2003-09-26 2003-10-29 Innovata Biomed Ltd Apparatus
SE0401654D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab A support structure for a medicament
GB0426780D0 (en) * 2004-12-07 2005-01-12 3M Innovative Properties Co Pressurized inhalation devices
AU2006241543A1 (en) * 2005-05-02 2006-11-09 Astrazeneca Ab An arrangement and a method for opening a cavity, a medical package and a dispensing device
CA2657639A1 (en) 2006-07-19 2008-01-24 Astrazeneca Ab Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
WO2008101992A1 (en) * 2007-02-21 2008-08-28 Novo Nordisk A/S Aerosol generating device with air flow control
GB0704928D0 (en) 2007-03-14 2007-04-25 Cambridge Consultants Dry powder inhalers
JP5356367B2 (ja) * 2007-04-30 2013-12-04 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド 吸入装置
WO2009008832A1 (en) 2007-07-12 2009-01-15 Astrazeneca Ab Medicament containing structure, method and inhalation device comprising such structure
AU2009213181B2 (en) * 2008-02-12 2012-02-23 Astrazeneca Ab Inhaler comprising a base having at least one sealed cavity containing medicament
RU2492877C2 (ru) * 2008-02-12 2013-09-20 Астразенека Аб Ингалятор, содержащий основание, имеющее большое количество содержащих лекарственное средство герметичных полостей
WO2010042036A1 (en) * 2008-10-08 2010-04-15 Astrazeneca Ab Inhaler with audible indicator means
BRPI0920390A2 (pt) * 2008-10-08 2019-09-24 Astrazeneca Ab inalador ativado por respiração

Also Published As

Publication number Publication date
MX2011003759A (es) 2011-05-03
CN102245239A (zh) 2011-11-16
CA2738822A1 (en) 2010-04-15
US20120125330A1 (en) 2012-05-24
NZ591956A (en) 2012-11-30
WO2010042033A1 (en) 2010-04-15
ES2579902T3 (es) 2016-08-17
UA101056C2 (ru) 2013-02-25
IL212074A0 (en) 2011-06-30
AU2009302956B8 (en) 2012-09-27
EA019293B1 (ru) 2014-02-28
EA201100487A1 (ru) 2011-12-30
JP5518082B2 (ja) 2014-06-11
EP2334358A1 (en) 2011-06-22
EP2334358A4 (en) 2014-04-02
KR20110074766A (ko) 2011-07-01
JP2012505017A (ja) 2012-03-01
EP2334358B1 (en) 2016-02-10
CN102245239B (zh) 2013-08-14
BRPI0920658A2 (pt) 2016-01-12
ZA201103334B (en) 2012-01-25
AU2009302956A1 (en) 2010-04-15
US9095670B2 (en) 2015-08-04
AU2009302956B2 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
CL2011000789A1 (es) Inhalador de medicamento, comprende una base que contiene al menos una cavidad con medicamento, una porcion de lamina metalica desprendible que cubre dicha cavidad, un elemento de separacion y un accionador que engancha el elemento de separacion, para separar la porcion de lamina, y un seguro accionado por un flujo de inhalacion
USD681106S1 (en) Type font
BR112012011128A2 (pt) composição farmacêutica compreendendo um agonista de glp-1, uma insulina e uma metionina
PE20141906A1 (es) Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
USD771807S1 (en) Injectable medication cooperating color encoded syringe
CL2011001254A1 (es) Combinacion farmaceutica que comprende un anticuerpo que reconoce especificamente a cd38 y al menos melfalan; y su uso para el tratamiento contra el cancer.
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
MX367241B (es) Uso de anticuerpos contra claudina 18.2 en una terapia de combinación para el tratamiento de cáncer.
GT200500384A (es) Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada
ECSP10010216A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
MX374694B (es) USO DE 1-CLORO-4-(ß-D-GLUCOPIRANOS-1-IL)-2-[4-((S)-TETRAHIDROFURAN-3-ILOXI)-BENCIL]-BENCENO EN COMBINACIÓN CON INSULINA PARA REDUCIR LA DOSIS DE INSULINA Y PARA MEJORAR EL CONTROL GLUCÉMICO EN PACIENTES CON DIABETES MELLITUS.
CL2014002863A1 (es) Sistema para administrar un medicamento para pacientes que respiran espontaneamente, que comprende un cateter flexible, primeros medios de bombeo, segundos medios de bombeo y un sensor de presion; metodo; kit
BR112015022465A2 (pt) método para tratamento não-tóxico para síndrome de abstinência de drogas
BR112015017451A2 (pt) formulações farmacêuticas resistentes à violação
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
ES2425315R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria
GT201400012A (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
MX2014002159A (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
CL2011001885A1 (es) Tableta bicapa oral en donde la primera capa comprende al compuesto de formula i (elvitegravir) y al compuesto de formula ii, y la segunda capa comprende al compuesto de formula iii (emtricitabina) y a la sal de formula iv (sal de tenofovir); metodo para la preparacion, util en el tratar infecciones por vih.
CL2011000806A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
AR058188A1 (es) Aguja para perforar capsulas con polvos para la inhalacion
AR097469A1 (es) Conjunto para un dispositivo de administración de medicamento, y dispositivo de administración de medicamento y método para producir un conjunto para un dispositivo de administración de medicamento
MX2016001384A (es) Metodos para incrementar el volumen espiratorio forzado en pacientes asmaticos que usan benralizumab.
USD663068S1 (en) Linear lighting track
BR112015014125A2 (pt) conjunto de travamento para impedir distribuição de dose a partir de dispositivo de distribuição de medicamento